NASDAQ:EQ

Equillium Stock Insider Trading

Healthcare > Biotechnology

Buy EQ

*Your capital is at risk

$3.11

+0.320 (+11.47%)

At Close: Jun 03, 2026

Equillium Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -17.51. In total, the insiders bought 15.92M and sold 2.26M EQ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-17.51
● Buy	15.92M shares
● Sell	2.26M shares
69% Buy Activity Weak Positive Correlation
Sell Signal Low Confidence Mar 09, 2026 Analysis Breakdown: Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	175 000 Value: $137.4K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	125 000 Value: $98.1K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	100 000 Value: $78.5K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	90 000 Value: $70.7K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	52 500 Value: $41.2K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Connelly Stephen Chief Scientific Officer	Officer	42 534 Value: $33.4K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Connelly Stephen Chief Scientific Officer	Officer	42 534 Value: $119.1K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Connelly Stephen Chief Scientific Officer	Officer	100 000 Value: $503.0K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Steel Bruce D. President And CEO	CEO / President	245 000 Value: $192.3K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Steel Bruce D. President And CEO	CEO / President	410 000 Value: $321.9K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Bradbury Daniel Executive Chairman	CEO / President	50 000 Value: $53.0K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Bradbury Daniel Executive Chairman	CEO / President	36 000 Value: $181.1K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Bradbury Daniel Executive Chairman	CEO / President	28 708 Value: $101.3K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Bradbury Daniel Executive Chairman	CEO / President	38 000 Value: $136.4K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Bradbury Daniel Executive Chairman	CEO / President	90 000 Value: $644.4K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Steel Bruce D. President And CEO	CEO / President	325 000 Value: $255.1K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Keyes Jason A Chief Financial Officer	C-Suite Officer	100 000 Value: $78.5K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Keyes Jason A Chief Financial Officer	C-Suite Officer	90 000 Value: $70.7K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Keyes Jason A Chief Financial Officer	C-Suite Officer	70 000 Value: $55.0K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Keyes Jason A Chief Financial Officer	C-Suite Officer	125 000 Value: $482.5K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Keyes Jason A Chief Financial Officer	C-Suite Officer	90 000 Value: $220.5K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Keyes Jason A Chief Financial Officer	C-Suite Officer	175 000 Value: $185.5K
Feb 14, 2025 Sell	Employee Stock Option (right to buy) D-Return	Keyes Jason A Chief Financial Officer	C-Suite Officer	100 000 Value: $503.0K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Tom Penny Principal Accounting Officer	Officer	100 000 Value: $78.5K
Feb 14, 2025 Buy	Employee Stock Option (right to buy) A-Award	Tom Penny Principal Accounting Officer	Officer	65 000 Value: $51.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EQUILLIUM INC.

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...

Read Full Profile Here